Paper36978147
APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
Butler K and 1 other. J Hematol Oncol, 2023. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential. Papers, record 36978147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clinical Relevance | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Mutagenesis | |
| Mutation | |
| Peptides | |
| Cytidine Deaminase | |
| Tumor Microenvironment | |
| APOBEC Deaminases |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Intramural | NIH HHS | United States | PubMed | PubMed | |
| ZIABC012091 | NIH | NIH RePORTER |
References207
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33849962 | Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33849962 | PubMed |
| 2 | 27321955 | Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27321955 | PubMed |
| 3 | 25163501 | Biological function of activation-induced cytidine deaminase (AID). | Biomed J | 2014 | https://conductscience.org/library/papers/25163501 | PubMed |
| 4 | 26459911 | The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population. | Sci Rep | 2015 | https://conductscience.org/library/papers/26459911 | PubMed |
| 5 | 20192759 | The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. | Annu Rev Biochem | 2010 | https://conductscience.org/library/papers/20192759 | PubMed |
| 6 | 33863885 | An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. | Nat Commun | 2021 | https://conductscience.org/library/papers/33863885 | PubMed |
| 7 | 26178819 | The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells. | Sci Rep | 2015 | https://conductscience.org/library/papers/26178819 | PubMed |
| 8 | 15098018 | Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. | Nat Struct Mol Biol | 2004 | https://conductscience.org/library/papers/15098018 | PubMed |
| 9 | 27643540 | Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. | Nat Genet | 2016 | https://conductscience.org/library/papers/27643540 | PubMed |
| 10 | 24728294 | Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. | Nat Genet | 2014 | https://conductscience.org/library/papers/24728294 | PubMed |
| 11 | 25650088 | Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma. | Leukemia | 2015 | https://conductscience.org/library/papers/25650088 | PubMed |
| 12 | 23852170 | An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. | Nat Genet | 2013 | https://conductscience.org/library/papers/23852170 | PubMed |
| 13 | 32719516 | APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis. | Nat Genet | 2020 | https://conductscience.org/library/papers/32719516 | PubMed |
| 14 | 25401976 | FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis. | Oncotarget | 2015 | https://conductscience.org/library/papers/25401976 | PubMed |
| 15 | 35768438 | The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma. | Nat Commun | 2022 | https://conductscience.org/library/papers/35768438 | PubMed |
| 16 | 16926856 | Mechanism of homologous recombination: mediators and helicases take on regulatory functions. | Nat Rev Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16926856 | PubMed |
| 17 | 33947663 | Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33947663 | PubMed |
| 18 | 27581627 | Role of E542 and E545 missense mutations of PIK3CA in breast cancer: a comparative computational approach. | J Biomol Struct Dyn | 2017 | https://conductscience.org/library/papers/27581627 | PubMed |
| 19 | 24910434 | APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. | Cell Rep | 2014 | https://conductscience.org/library/papers/24910434 | PubMed |
| 20 | 35673559 | APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases. | Theranostics | 2022 | https://conductscience.org/library/papers/35673559 | PubMed |
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42884106 | Pan-Cancer APOBEC Mutagenesis, Immune Microenvironment, and Clinical Outcome: A Comprehensive Multi-Omics Analysis of All Ten Family Members Across 9653 TCGA Tumors. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42884106 | PubMed |
| 42853602 | Punctuated mutagenesis promotes multi-step evolutionary adaptation in human cancers. | Elife | 2026 | https://conductscience.org/library/papers/42853602 | PubMed |
| 42845502 | Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator. | Res Sq | 2026 | https://conductscience.org/library/papers/42845502 | PubMed |
| 42791387 | Unraveling the lexicon of complex mutational phenomena in human cancers. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42791387 | PubMed |
| 42717521 | APOBEC3 activity and DNA polymerase-ε deficiency are associated with distinct IDH1 R132 hotspot mutations. | Mol Oncol | 2026 | https://conductscience.org/library/papers/42717521 | PubMed |
| 42582228 | Hallmarks of lung cancer driven by inhalable particulate matter: From cell-intrinsic oncogenic traits to microenvironment remodeling. | Innovation (Camb) | 2026 | https://conductscience.org/library/papers/42582228 | PubMed |
| 42562966 | Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/42562966 | PubMed |
| 42523379 | APOBEC3G expression marks a TMB-high, T cell-inflamed tumor state and is associated with response to immune checkpoint blockade in multiple cancer cohorts. | bioRxiv | 2026 | https://conductscience.org/library/papers/42523379 | PubMed |
| 42472831 | Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42472831 | PubMed |
| 42259884 | Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/42259884 | PubMed |
| 42158468 | Integrative Genomic and Functional Analysis Reveals NF1 Loss as a Modifier of DNA Damage and Replication Stress Responses in Ovarian Cancer. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42158468 | PubMed |
| 42113333 | Dynamic ecosystems of tumor drug resistance mechanisms: from molecular heterogeneity to systemic interventions. | Apoptosis | 2026 | https://conductscience.org/library/papers/42113333 | PubMed |
| 42059071 | KSHV Genome in Saliva, Whole Blood and Kaposi's Sarcoma Biopsy Specimens in Republic of Congo: Phylogenetic Analysis and an APOBEC3B Mutational Signature. | J Med Virol | 2026 | https://conductscience.org/library/papers/42059071 | PubMed |
| 42027431 | Comprehensive analysis of mutational signatures and corresponding driver genes in cervical cancer from Xinjiang. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/42027431 | PubMed |
| 41938780 | Host restriction factors and p17-Driven inflammaging in HIV-1: From molecular pathogenesis to functional cure. | AIMS Microbiol | 2026 | https://conductscience.org/library/papers/41938780 | PubMed |
| 41858889 | Interferon signaling gene expression, and DNA methylation interactions in Sjögren's disease via mendelian randomization. | iScience | 2026 | https://conductscience.org/library/papers/41858889 | PubMed |
| 41826799 | Competing subclones and fitness diversity shape tumor evolution across cancer types. | Bioinformatics | 2026 | https://conductscience.org/library/papers/41826799 | PubMed |
| 41756300 | Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions. | Front Immunol | 2026 | https://conductscience.org/library/papers/41756300 | PubMed |
| 41737841 | The evolving mpox threat (2022-2024): clade dynamics, immune evasion, and escalating global health challenges. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41737841 | PubMed |
| 41606303 | Five dominant amino acid substitution signatures shape tumour immunity. | Mol Syst Biol | 2026 | https://conductscience.org/library/papers/41606303 | PubMed |
Genes62
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36978147
GET https://conductscience.org/api/papers/v1/36978147/references?page=2